Kamada (KMDA)

Kamada (KMDA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $466M; returns 1 day +0.5%, 1 week +0.1%, 1 year +13.4%.

Kamada Ltd. is an Israeli-based, vertically integrated global biopharmaceutical company focused on the development, production, and marketing of specialty plasma-derived protein therapeutics. The company primarily generates revenue through two segments: Proprietary Products and Distribution.

Groups KMDA belongs to

• Dividend Payers
• Healthcare
• Biopharmaceutical
• Israel Companies
• Israel
• Plasma Collection
• Vertical Integration
• Biotechnology
• Rare Diseases
• Commercial Stage
• Specialty Chemicals
• Life Sciences
• Pharmaceuticals

KMDA financial model: income statement, cash flow and balance sheet